Scarica l'app Stockscreener
62.82
1.32%
0.82
Dopo l'orario di chiusura:
62.80
-0.02
-0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$62.00
Aprire:
$62.05
Volume 24 ore:
13.89M
Relative Volume:
0.90
Capitalizzazione di mercato:
$93.36B
Reddito:
$20.08B
Utile/perdita netta:
$2.89B
Rapporto P/E:
32.40
EPS:
1.9391
Flusso di cassa netto:
$3.66B
1 W Prestazione:
-10.47%
1M Prestazione:
-17.58%
6M Prestazione:
-34.71%
1 anno Prestazione:
-37.21%
Intervallo 1D:
$61.80
$63.20
Intervallo di 1 settimana:
$61.24
$70.13
Portata 52W:
$61.24
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are th - Benzinga
Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Why Boston Scientific's big dip could be a bigger opportunity - MSN
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp. Stock: Strong Growth in Medtech Amid Evolving Healthcare Demands - AD HOC NEWS
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific completes acquisition of California bladder treatment company - wbjournal.com
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) - GlobeNewswire
RBC Capital reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
RBC Capital reiterates Boston Scientific stock rating on growth outlook - Investing.com
Here are the largest manufacturers in Massachusetts - The Business Journals
Banque Pictet & Cie SA Has $25.83 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
BSX Price History for Boston Scientific Corp Stock - Barchart.com
[EFFECT] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific (NYSE: BSX) to acquire Penumbra in $374/share deal - Stock Titan
Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints - Insider Monkey
Boston Scientific (XSWX:BSX) Shiller PE Ratio : (As of Apr. 01, 2026) - GuruFocus
Nisa Investment Advisors LLC Sells 18,182 Shares of Boston Scientific Corporation $BSX - MarketBeat
List of 57 Acquisitions by Boston Scientific (Apr 2026) - Tracxn
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast - Yahoo Finance
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart
Boston Scientific presents Watchman FLX and EKOS endovascular system data - Medical Device Network
FDA clears Boston Scientific’s Asurys system for endoscopic procedures - Medical Device Network
UBS reiterates Boston Scientific stock Buy on trial success - Investing.com
Boston Scientific (BSX) Stock Plunges 9% on Watchman Trial Concerns and Rating Cut - Blockonomi
Boston Scientific (BSX) Stock Falls 9% After Watchman Trial Data and Analyst Downgrade - CoinCentral
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT) - theglobeandmail.com
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - theglobeandmail.com
Boston Scientific (BSX) Gets a Buy from Canaccord Genuity - theglobeandmail.com
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - MarketScreener
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm - PR Newswire
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. - Barron's
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
AI Models Turn More Positive on Boston Scientific, But Weak Technicals Temper Enthusiasm - TipRanks
Boston Scientific (BSX) Receives a Buy from RBC Capital - theglobeandmail.com
Boston Scientific Stock Tumbles 9% Following Raymond James Downgrade - TIKR.com
Can Boston Scientific Stock Surge 40% From Here? - Yahoo Finance
Is There An Opportunity In Boston Scientific (BSX) After Steep Recent Share Price Declines? - simplywall.st
Boston Scientific Corporation $BSX Stock Holdings Cut by J. Safra Sarasin Holding AG - MarketBeat
Boston Scientific dives after disappointing clinical trial results - medwatch.com
Raymond James downgrades Boston Scientific (BSX) - MSN
Boston Scientific Corporation $BSX Shares Purchased by Brookstone Capital Management - MarketBeat
Allspring Global Investments Holdings LLC Raises Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):